Zein-Based Nanoparticles as Oral Carriers for Insulin Delivery

Mahmood, 2019, SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs, Adv. Drug Deliv. Rev., 142, 91, 10.1016/j.addr.2018.07.001

Sim, 2016, Nanomedicines for oral administration based on diverse nanoplatform, J. Pharm. Investig., 46, 351, 10.1007/s40005-016-0255-y

Brown, 2020, Materials for oral delivery of proteins and peptides, Nat. Rev. Mater., 5, 127, 10.1038/s41578-019-0156-6

Ahmad, 2012, Oral Nano-Insulin Therapy: Current Progress on Nanoparticle-Based Devices for Intestinal Epithelium-Targeted Insulin Delivery, J. Nanomed. Nanotechnol., s4, 007

Frizzell, 2020, Biomaterial Approaches for Understanding and Overcoming Immunological Barriers to Effective Oral Vaccinations, Adv. Funct. Mater., 30, 1907170, 10.1002/adfm.201907170

Langguth, 1997, The challenge of proteolysis enzymes in intestinal peptide delivery, J. Control. Release, 46, 39, 10.1016/S0168-3659(96)01586-6

Li, 2013, Spatial configuration and composition of charge modulates transport into a mucin hydrogel barrier, Biophys. J., 105, 1357, 10.1016/j.bpj.2013.07.050

Johansson, 2011, Composition and functional role of the mucus layers in the intestine, Cell. Mol. Life Sci., 68, 3635, 10.1007/s00018-011-0822-3

Hwang, 2014, Advances in oral macromolecular drug delivery, Expert Opin. Drug Deliv., 11, 1955, 10.1517/17425247.2014.945420

Lee, 2018, Tight junction in the intestinal epithelium: Its association with diseases and regulation by phytochemicals, J. Immunol. Res., 2018, 2645465, 10.1155/2018/2645465

Xu, 2019, Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: A review, Trends Food Sci. Technol., 86, 399, 10.1016/j.tifs.2019.02.050

Li, R., Laurent, F., Taverner, A., Mackay, J., De Bank, P.A., and Mrsny, R.J. (2021). Intestinal transcytosis of a protein cargo and nanoparticles mediated by a non-toxic form of pseudomonas aeruginosa exotoxin A. Pharmaceutics, 13.

Shakweh, 2004, Particle uptake by Peyer’s patches: A pathway for drug and vaccine delivery, Expert Opin. Drug Deliv., 1, 141, 10.1517/17425247.1.1.141

Vakilian, 2019, A review on insulin trafficking and exocytosis, Gene, 706, 52, 10.1016/j.gene.2019.04.063

McGinn, 2016, Investigations into the absorption of insulin and insulin derivatives from the small intestine of the anaesthetised rat, J. Control. Release, 232, 120, 10.1016/j.jconrel.2016.04.002

Coran, 2010, Oral insulin stimulates intestinal epithelial cell turnover in correlation with insulin-receptor expression along the villus-crypt axis in a rat model of short bowel syndrome, Pediatr. Surg. Int., 26, 37, 10.1007/s00383-009-2520-x

Hall, 2020, Insulin receptor endocytosis in the pathophysiology of insulin resistance, Exp. Mol. Med., 52, 911, 10.1038/s12276-020-0456-3

2000, Oral peptide drug delivery: Polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro, Biomaterials, 21, 1499, 10.1016/S0142-9612(00)00039-9

Ibie, 2019, Complexation of novel thiomers and insulin to protect against in vitro enzymatic degradation–towards oral insulin delivery, Drug Dev. Ind. Pharm., 45, 67, 10.1080/03639045.2018.1517776

Torchilin, 2005, Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov., 4, 145, 10.1038/nrd1632

Wong, 2018, Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus, Int. J. Pharm., 549, 201, 10.1016/j.ijpharm.2018.07.041

Li, 2014, Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading, Int. J. Pharm., 477, 390, 10.1016/j.ijpharm.2014.10.039

Irache, 2011, Nanomedicine: Novel approaches in human and veterinary therapeutics, Vet. Parasitol., 180, 47, 10.1016/j.vetpar.2011.05.028

Fonte, 2014, Polymer-based nanoparticles for oral insulin delivery: Revisited approaches, Biotechnol. Adv., 33, 1342, 10.1016/j.biotechadv.2015.02.010

Hirlekar, 2017, Oral insulin delivery: Novel strategies, Asian J. Pharm., 11, S434

Paques, 2014, Preparation methods of alginate nanoparticles, Adv. Colloid Interface Sci., 209, 163, 10.1016/j.cis.2014.03.009

Luo, Y., and Wang, Q. (2014). Zein-based micro- and nano-particles for drug and nutrient delivery: A review. J. Appl. Polym. Sci., 131.

Penalva, 2015, Zein-Based Nanoparticles Improve the Oral Bioavailability of Resveratrol and Its Anti-inflammatory Effects in a Mouse Model of Endotoxic Shock, J. Agric. Food Chem., 63, 5603, 10.1021/jf505694e

Inchaurraga, 2020, Zein-based nanoparticles for the oral delivery of insulin, Drug Deliv. Transl. Res., 10, 1601, 10.1007/s13346-020-00796-3

Esparza, 2015, Zein nanoparticles for oral folic acid delivery, J. Drug Deliv. Sci. Technol., 30, 450, 10.1016/j.jddst.2015.06.012

Reboredo, 2021, Preparation and evaluation of PEG-coated zein nanoparticles for oral drug delivery purposes, Int. J. Pharm., 597, 120287, 10.1016/j.ijpharm.2021.120287

Arangoa, 2002, Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles, Int. J. Pharm., 242, 129, 10.1016/S0378-5173(02)00182-5

Doktorovova, 2012, Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN), Eur. J. Pharm. Sci., 45, 606, 10.1016/j.ejps.2011.12.016

Vizmanos, 2021, Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans, Drug Deliv. Transl. Res., 11, 647, 10.1007/s13346-021-00919-4

Lechanteur, 2017, Elucidation of the impact of cell culture conditions of Caco-2 cell monolayer on barrier integrity and intestinal permeability, Eur. J. Pharm. Biopharm., 119, 137, 10.1016/j.ejpb.2017.06.013

Hilgendorf, 2000, Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport, J. Pharm. Sci., 89, 63, 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6

Lazzaro, 2014, The genetics of immunity, Genetics, 197, 467, 10.1534/genetics.114.165449

Lucio, 2017, Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans, Eur. J. Pharm. Biopharm., 121, 104, 10.1016/j.ejpb.2017.09.018

Zhang, 2010, PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel, Comput. Methods Programs Biomed., 99, 306, 10.1016/j.cmpb.2010.01.007

Homayun, B., Lin, X., and Choi, H.J. (2019). Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics, 11.

Wu, 2019, A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels, J. Pharm. Sci., 108, 2143, 10.1016/j.xphs.2019.01.027

Jain, 2018, Protein Nanoparticles: Promising Platforms for Drug Delivery Applications, ACS Biomater. Sci. Eng., 4, 3939, 10.1021/acsbiomaterials.8b01098

Pascoli, 2018, Zein nanoparticles and strategies to improve colloidal stability: A mini-review, Front. Chem., 6, 6, 10.3389/fchem.2018.00006

Reddy, N., and Rapisarda, M. (2021). Properties and applications of nanoparticles from plant proteins. Materials, 14.

Calvez, J., Benoit, S., Fleury, L., Khodorova, N., Piedcoq, J., Tomé, D., Airinei, G., Ben-Amouzig, R., and Gaudichon, C. (2019). True Ileal Protein Digestibility of Zein and Whey Protein Isolate in Healthy Humans (OR27-06-19). Curr. Dev. Nutr., 3.

Ye, 2017, Low uptake of silica nanoparticles in Caco-2 intestinal epithelial barriers, Beilstein J. Nanotechnol., 8, 1396, 10.3762/bjnano.8.141

Reale, 2021, Co-culture model of Caco-2/HT29-MTX cells: A promising tool for investigation of phycotoxins toxicity on the intestinal barrier, Chemosphere, 273, 128497, 10.1016/j.chemosphere.2020.128497

Pierce, 2001, Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family, Genes Dev., 15, 672, 10.1101/gad.867301

Aranaz, 2021, In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions, Acta Pharm. Sin. B, 11, 989, 10.1016/j.apsb.2021.02.020

Cohen, J.D., and Sundaram, M.V.C. (2020). Elegans apical extracellular matrices shape epithelia. J. Dev. Biol., 8.

Sonaje, 2009, In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery, Biomaterials, 30, 2329, 10.1016/j.biomaterials.2008.12.066

Jin, 2012, Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport, Biomaterials, 33, 1573, 10.1016/j.biomaterials.2011.10.075

Sarmento, 2007, Alginate/chitosan nanoparticles are effective for oral insulin delivery, Pharm. Res., 24, 2198, 10.1007/s11095-007-9367-4

Mumuni, 2020, Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment, Carbohydr. Polym., 229, 115506, 10.1016/j.carbpol.2019.115506

Chen, 2017, Eudragit S100-Coated Chitosan Nanoparticles Co-loading Tat for Enhanced Oral Colon Absorption of Insulin, AAPS PharmSciTech, 18, 1277, 10.1208/s12249-016-0594-z

Guo, 2016, Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: Preparation and evaluation, Drug Deliv., 23, 2003, 10.3109/10717544.2015.1048489

Xu, 2017, Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin, Mater. Sci. Eng. C, 78, 420, 10.1016/j.msec.2017.04.113

2020, Encapsulation of an insulin-modified phosphatidylcholine complex in a self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin delivery, J. Drug Deliv. Sci. Technol., 57, 101622, 10.1016/j.jddst.2020.101622

Yazdi, 2020, Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies, Colloids Surf. B Biointerfaces, 194, 111203, 10.1016/j.colsurfb.2020.111203

Ali, 2019, Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity, Int. J. Pharm., 571, 118708, 10.1016/j.ijpharm.2019.118708

Bao, 2021, Insulin- And cholic acid-loaded zein/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin, J. Mater. Chem. B, 9, 6234, 10.1039/D1TB00806D